id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
EPA-HQ-OPP-2012-0565-0071,EPA,EPA-HQ-OPP-2012-0565,Pesticide Registration Review: Decisions and Case Closures for Several Pesticides,Notice,,2024-07-15T04:00:00Z,2024,7,,,2024-07-19T18:22:09Z,2024-15476,0,0,09000064865ef866
EPA-HQ-OPP-2012-0565-0072,EPA,EPA-HQ-OPP-2012-0565,"Norflurazon Response to Tessenderlo Kerley Inc (TKI) Comments on the Norflurazon Proposed Interim Registration Review Decision (PID), Published December 19, 2022 20240627",Supporting & Related Material,Comment Response,2024-07-15T04:00:00Z,2024,7,,,2024-07-16T00:33:57Z,,0,0,09000064865dd2ba
EPA-HQ-OPP-2012-0565-0073,EPA,EPA-HQ-OPP-2012-0565,Norflurazon Interim Registration Review Decision Case Number 0229 20240705,Supporting & Related Material,Decision,2024-07-15T04:00:00Z,2024,7,,,2024-07-16T00:33:42Z,,0,0,09000064865dd2bb
EPA-HQ-OPP-2012-0565-0070,EPA,EPA-HQ-OPP-2012-0565,Norflurazon TKI Meeting Notes 20240506,Supporting & Related Material,Meeting Materials,2024-07-11T04:00:00Z,2024,7,,,2024-07-12T00:32:06Z,,0,0,09000064865c3b1d
EPA-HQ-OPP-2012-0565-0061,EPA,EPA-HQ-OPP-2012-0565,"Authorization to extend the public comment period for the DCNA, etofenprox, norflurazon, and thiophanate-methyl/carbendazim proposed interim decisions",Other,,2023-02-24T05:00:00Z,2023,2,2023-02-24T05:00:00Z,,2024-07-13T22:09:26Z,,0,0,09000064857003ed
EPA-HQ-OPP-2012-0565-0046,EPA,EPA-HQ-OPP-2012-0565,"Norflurazon: Addendum to the Preliminary Ecological Risk Assessment for Registration Review (September 21, 2022)",Supporting & Related Material,Risk Assessment,2022-12-23T05:00:00Z,2022,12,,,2022-12-24T01:48:01Z,,0,0,0900006485547d5d
EPA-HQ-OPP-2012-0565-0055,EPA,EPA-HQ-OPP-2012-0565,"Norflurazon: Tier I Update Review of Human Incidents and Epidemiology for Proposed Interim Decision (PID) (May 9, 2022)",Supporting & Related Material,Memorandum,2022-12-23T05:00:00Z,2022,12,,,2022-12-24T01:49:48Z,,0,0,0900006485547dff
EPA-HQ-OPP-2012-0565-0044,EPA,EPA-HQ-OPP-2012-0565,Pesticide Registration Review: Proposed Interim Decisions for Several Pesticides,Notice,,2022-12-23T05:00:00Z,2022,12,2022-12-23T05:00:00Z,2023-03-24T03:59:59Z,2024-07-11T01:00:31Z,2022-27936,0,0,090000648554fa10
EPA-HQ-OPP-2012-0565-0048,EPA,EPA-HQ-OPP-2012-0565,"Norflurazon:  Revised Human Health Risk Assessment in Support of Registration Review (September 26, 2022)",Supporting & Related Material,Risk Assessment,2022-12-23T05:00:00Z,2022,12,,,2022-12-24T01:51:46Z,,0,0,0900006485547d5f
EPA-HQ-OPP-2012-0565-0052,EPA,EPA-HQ-OPP-2012-0565,"Norflurazon (105801) Screening Level Usage Analysis (SLUA) (June 23, 2021)",Supporting & Related Material,Analysis,2022-12-23T05:00:00Z,2022,12,,,2022-12-24T01:49:14Z,,0,0,0900006485547dac
EPA-HQ-OPP-2012-0565-0053,EPA,EPA-HQ-OPP-2012-0565,"Norflurazon. Registration Review. Summary of Analytical Chemistry and Residue Data (September 27, 2017)",Supporting & Related Material,Memorandum,2022-12-23T05:00:00Z,2022,12,,,2022-12-24T01:49:28Z,,0,0,0900006485547dad
EPA-HQ-OPP-2012-0565-0051,EPA,EPA-HQ-OPP-2012-0565,"Norflurazon (PC 105801): Use, Usage, and Benefits Information Including Impacts from Potential Mitigation (December 1, 2022)",Supporting & Related Material,Memorandum,2022-12-23T05:00:00Z,2022,12,,,2022-12-24T01:51:31Z,,0,0,0900006485547db0
EPA-HQ-OPP-2012-0565-0057,EPA,EPA-HQ-OPP-2012-0565,D462850 Revised Norflurazon Occupational Handler Calculator,Supporting & Related Material,Data,2022-12-23T05:00:00Z,2022,12,,,2022-12-24T01:50:02Z,,0,0,0900006485547e00
EPA-HQ-OPP-2012-0565-0050,EPA,EPA-HQ-OPP-2012-0565,"Norflurazon: Responses to Comments on the “Draft Human Health Risk Assessment in Support of Registration Review, D432685” (June 20, 2018)",Supporting & Related Material,Comment Response,2022-12-23T05:00:00Z,2022,12,,,2022-12-24T01:48:46Z,,0,0,0900006485547daa
EPA-HQ-OPP-2012-0565-0059,EPA,EPA-HQ-OPP-2012-0565,"Norflurazon: Responses to Additional Comments on the “Draft Human Health Risk Assessment in Support of Registration Review, D432685” Regarding Dermal Studies (June 12, 2019)",Supporting & Related Material,Comment Response,2022-12-23T05:00:00Z,2022,12,,,2022-12-24T01:48:32Z,,0,0,0900006485547dab
EPA-HQ-OPP-2012-0565-0045,EPA,EPA-HQ-OPP-2012-0565,"Norflurazon: Addendum to the Drinking Water Assessment for Registration Review (August 8, 2022)",Supporting & Related Material,Risk Assessment,2022-12-23T05:00:00Z,2022,12,,,2022-12-24T01:50:44Z,,0,0,0900006485547a06
EPA-HQ-OPP-2012-0565-0047,EPA,EPA-HQ-OPP-2012-0565,Norflurazon Proposed Interim Registration Review Decision Case Number 0229,Supporting & Related Material,Decision,2022-12-23T05:00:00Z,2022,12,,,2022-12-24T01:48:18Z,,0,0,0900006485547d5e
EPA-HQ-OPP-2012-0565-0049,EPA,EPA-HQ-OPP-2012-0565,"Norflurazon: Revised Occupational and Residential Exposure and Risk Assessment in Support of the Registration Review (September 22, 2022)",Supporting & Related Material,Risk Assessment,2022-12-23T05:00:00Z,2022,12,,,2022-12-24T01:50:58Z,,0,0,0900006485547d0f
EPA-HQ-OPP-2012-0565-0056,EPA,EPA-HQ-OPP-2012-0565,"Norflurazon. Updated Chronic Dietary (Food and Drinking Water) Exposure and Risk Assessments in Support of Registration Review (September 22, 2022)",Supporting & Related Material,Risk Assessment,2022-12-23T05:00:00Z,2022,12,,,2022-12-24T01:51:14Z,,0,0,0900006485547daf
EPA-HQ-OPP-2012-0565-0054,EPA,EPA-HQ-OPP-2012-0565,"Norflurazon: Summary of Hazard and Science Policy Council (HASPOC) Meetings on February 7th and March 7th, 2019. Revisit of the Recommendations on the need for Comparative Thyroid Assay. (March 14, 2019)",Supporting & Related Material,Memorandum,2022-12-23T05:00:00Z,2022,12,,,2022-12-24T01:50:29Z,,0,0,0900006485547d60
EPA-HQ-OPP-2012-0565-0058,EPA,EPA-HQ-OPP-2012-0565,D462850 Revised Norflurazon Spray Drift Calculator,Supporting & Related Material,Data,2022-12-23T05:00:00Z,2022,12,,,2022-12-24T01:50:15Z,,0,0,0900006485547e01
EPA-HQ-OPP-2012-0565-0043,EPA,EPA-HQ-OPP-2012-0565,Norflurazon – EFED Response to Public Comments on the Drinking Water Assessment and Preliminary Ecological Risk Assessment in Support of the Registration Review of Norflurazon,Supporting & Related Material,Comment Response,2021-09-27T04:00:00Z,2021,9,,,2021-09-28T00:37:39Z,,0,0,0900006484d955cb
EPA-HQ-OPP-2012-0565-0033,EPA,EPA-HQ-OPP-2012-0565,Authorization to extend the public comment period for certain registration dockets,Other,,2018-02-06T05:00:00Z,2018,2,,,2018-02-07T03:46:11Z,,0,0,0900006482ef4f5f
EPA-HQ-OPP-2012-0565-0023,EPA,EPA-HQ-OPP-2012-0565,Registration Review: Tier 2 Drinking Water Assessment for Norflurazon,Supporting & Related Material,Risk Assessment,2017-12-15T05:00:00Z,2017,12,,,2017-12-16T01:40:42Z,,0,0,0900006482c85db4
EPA-HQ-OPP-2012-0565-0024,EPA,EPA-HQ-OPP-2012-0565,Registration Review: Preliminary Risk Assessment for Environmental Fate and Ecological Risk for Norflurazon,Supporting & Related Material,Risk Assessment,2017-12-15T05:00:00Z,2017,12,,,2017-12-16T01:40:51Z,,0,0,0900006482c85db5
EPA-HQ-OPP-2012-0565-0028,EPA,EPA-HQ-OPP-2012-0565,"Norflurazon: Summary of Hazard and Science Policy Council (HASPOC)
Meeting on August 4, 2016: Recommendations on the Need for an
Immunotoxicity Study (870. 7800).",Supporting & Related Material,Report,2017-12-15T05:00:00Z,2017,12,,,2017-12-16T01:40:22Z,,0,0,0900006482c86de6
EPA-HQ-OPP-2012-0565-0022,EPA,EPA-HQ-OPP-2012-0565,Registration Reviews: Draft Human Health and/or Ecological Risk Assessments for Several Pesticides,Notice,,2017-12-15T05:00:00Z,2017,12,2017-12-15T05:00:00Z,2018-03-16T03:59:59Z,2018-03-16T01:04:10Z,2017-27098,0,0,0900006482d15818
EPA-HQ-OPP-2012-0565-0025,EPA,EPA-HQ-OPP-2012-0565,Norflurazon: Draft Human Health Risk Assessment in Support of Registration Review.,Supporting & Related Material,Risk Assessment,2017-12-15T05:00:00Z,2017,12,,,2017-12-16T01:41:02Z,,0,0,0900006482c85db6
EPA-HQ-OPP-2012-0565-0029,EPA,EPA-HQ-OPP-2012-0565,"Norflurazon: Summary of Hazard and Science Policy Council (HASPOC)
Meetings of July 12, 2012: Recommendations on the requirement of a subchronic inhalation study and the neurotoxicity screening battery for norflurazon.",Supporting & Related Material,Report,2017-12-15T05:00:00Z,2017,12,,,2017-12-16T01:40:12Z,,0,0,0900006482c86de7
EPA-HQ-OPP-2012-0565-0026,EPA,EPA-HQ-OPP-2012-0565,"Norflurazon: Summary of Hazard and Science Policy Council (HASPOC)
Meeting on June 15, 2017: Recommendations on the Need for Comparative
Thyroid Assay.",Supporting & Related Material,Report,2017-12-15T05:00:00Z,2017,12,,,2017-12-16T01:41:32Z,,0,0,0900006482c85db7
EPA-HQ-OPP-2012-0565-0030,EPA,EPA-HQ-OPP-2012-0565,Norflurazon (105801) - Label Tracking Report,Supporting & Related Material,Report,2017-12-15T05:00:00Z,2017,12,,,2017-12-16T01:41:12Z,,0,0,0900006482c86de8
EPA-HQ-OPP-2012-0565-0027,EPA,EPA-HQ-OPP-2012-0565,"Norflurazon: Summary of Hazard and Science Policy Council (HASPOC)
Meeting on May 18, 2017: Recommendation on the Need for a Dermal Toxicity Study.",Supporting & Related Material,Report,2017-12-15T05:00:00Z,2017,12,,,2017-12-16T01:41:22Z,,0,0,0900006482c85db8
EPA-HQ-OPP-2012-0565-0020,EPA,EPA-HQ-OPP-2012-0565,"Norflurazon:  Weight of Evidence Analysis of Potential Interaction with the Estrogen, Androgen, or Thyroid Pathways ( WOE)",Supporting & Related Material,Analysis,2015-09-11T04:00:00Z,2015,9,,,2015-09-12T00:32:30Z,,0,0,0900006481b51aab
EPA-HQ-OPP-2012-0565-0021,EPA,EPA-HQ-OPP-2012-0565,Norflurazon: Data Evaluation Records (DERs) for EDSP Tier 1 Assays,Supporting & Related Material,Evaluation,2015-09-11T04:00:00Z,2015,9,,,2015-09-12T00:32:41Z,,0,0,0900006481c54d1f
EPA-HQ-OPP-2012-0565-0019,EPA,EPA-HQ-OPP-2012-0565,"Generic Data Call-In, GDCI-105801-1294.Norflurazon.Docket",Supporting & Related Material,,2013-07-11T04:00:00Z,2013,7,,,2013-07-11T22:03:31Z,,0,0,0900006481360e02
EPA-HQ-OPP-2012-0565-0018,EPA,EPA-HQ-OPP-2012-0565,4/11/13 - Norflurazon Focus Meeting Contact Sheet,Supporting & Related Material,Meeting Materials,2013-05-31T04:00:00Z,2013,5,,,2013-05-31T19:21:14Z,,0,0,09000064812e4126
EPA-HQ-OPP-2012-0565-0017,EPA,EPA-HQ-OPP-2012-0565,4/11/13 - Norflurazon  Focus Meeting Notes (4/11/2013--With Syngenta),Supporting & Related Material,Meeting Materials,2013-05-31T04:00:00Z,2013,5,,,2013-05-31T19:21:25Z,,0,0,09000064812e4125
EPA-HQ-OPP-2012-0565-0016,EPA,EPA-HQ-OPP-2012-0565,4/11/13 - Syngenta's Powerpoint Presentation,Supporting & Related Material,Meeting Materials,2013-05-31T04:00:00Z,2013,5,,,2013-05-31T19:21:03Z,,0,0,09000064812e4124
EPA-HQ-OPP-2012-0565-0011,EPA,EPA-HQ-OPP-2012-0565,2/11/13.  PRD Response to Comments,Supporting & Related Material,Comment Response,2013-04-09T04:00:00Z,2013,4,,,2013-04-09T14:08:16Z,,0,0,090000648122484b
EPA-HQ-OPP-2012-0565-0015,EPA,EPA-HQ-OPP-2012-0565,February 2013.  A Retrospective Analysis of the Immunotoxicity Study (OCSPP Test Guideline No. 870. 7800),Supporting & Related Material,Study,2013-04-09T04:00:00Z,2013,4,,,2013-04-09T14:08:51Z,,0,0,0900006481224885
EPA-HQ-OPP-2012-0565-0010,EPA,EPA-HQ-OPP-2012-0565,3/8/2013.  Norflurazon Final Work Plan,Supporting & Related Material,Work Plan,2013-04-09T04:00:00Z,2013,4,,,2013-04-09T14:07:55Z,,0,0,0900006481224822
EPA-HQ-OPP-2012-0565-0012,EPA,EPA-HQ-OPP-2012-0565,1/31/13.  EFED Response to Comments,Supporting & Related Material,Comment Response,2013-04-09T04:00:00Z,2013,4,,,2013-04-09T14:08:40Z,,0,0,090000648122484f
EPA-HQ-OPP-2012-0565-0013,EPA,EPA-HQ-OPP-2012-0565,1/15/13.  HED Response to Comments,Supporting & Related Material,Comment Response,2013-04-09T04:00:00Z,2013,4,,,2013-04-09T14:08:05Z,,0,0,0900006481224851
EPA-HQ-OPP-2012-0565-0014,EPA,EPA-HQ-OPP-2012-0565,8/15/12 - Norflurazon HASPOC Memorandum,Supporting & Related Material,Memorandum,2013-04-09T04:00:00Z,2013,4,,,2013-04-09T14:08:26Z,,0,0,0900006481224882
EPA-HQ-OPP-2012-0565-0005,EPA,EPA-HQ-OPP-2012-0565,5/3/12. Norflurazon: Review of Human Incidents,Supporting & Related Material,Memorandum,2012-09-26T04:00:00Z,2012,9,,,2012-09-26T15:58:50Z,,0,0,090000648111a56e
EPA-HQ-OPP-2012-0565-0003,EPA,EPA-HQ-OPP-2012-0565,8/27/12. Norflurazon: Human Health Risk Scoping Document in Support of Registration Review,Supporting & Related Material,Memorandum,2012-09-26T04:00:00Z,2012,9,,,2012-09-26T15:59:34Z,,0,0,090000648111a56c
EPA-HQ-OPP-2012-0565-0004,EPA,EPA-HQ-OPP-2012-0565,"8/9/12. Registration Review: Preliminary Problem Formulation for Environmental Fate and Ecological Risk, Endangered Species, and Drinking Water Assessments for Norflurazon",Supporting & Related Material,Memorandum,2012-09-26T04:00:00Z,2012,9,,,2012-09-26T15:59:12Z,,0,0,090000648111a56d
EPA-HQ-OPP-2012-0565-0001,EPA,EPA-HQ-OPP-2012-0565,Registration Reviews: Pesticide Dockets Opened for Review and Comment,Notice,,2012-09-26T04:00:00Z,2012,9,2012-09-26T04:00:00Z,2012-11-27T04:59:59Z,2012-11-27T03:01:23Z,2012-23520,0,0,090000648112937c
EPA-HQ-OPP-2012-0565-0002,EPA,EPA-HQ-OPP-2012-0565,9/14/12. Norflurazon Preliminary Work Plan,Supporting & Related Material,Work Plan,2012-09-26T04:00:00Z,2012,9,,,2012-09-26T15:59:23Z,,0,0,0900006481119bab
EPA-HQ-OPP-2012-0565-0008,EPA,EPA-HQ-OPP-2012-0565,11/4/11. Norflurazon Screening Level Usage Analysis (SLUA),Supporting & Related Material,Data,2012-09-26T04:00:00Z,2012,9,,,2012-09-26T15:59:55Z,,0,0,090000648111a571
EPA-HQ-OPP-2012-0565-0006,EPA,EPA-HQ-OPP-2012-0565,4/12/12. BEAD Chemical Profile for Registration Review: Norflurazon (105801,Supporting & Related Material,Memorandum,2012-09-26T04:00:00Z,2012,9,,,2012-09-26T15:59:44Z,,0,0,090000648111a56f
EPA-HQ-OPP-2012-0565-0007,EPA,EPA-HQ-OPP-2012-0565,1/18/12. Norflurazon Appendix A,Supporting & Related Material,Data,2012-09-26T04:00:00Z,2012,9,,,2012-09-26T15:59:01Z,,0,0,090000648111a570